Economic footprint of Novartis Germany
As a result, Novartis makes an important economic contribution to regional economic performance and employment, especially in structurally weak regions, such as the Barleben site in Saxony-Anhalt (see case study).
In the second part of the publication, four case studies were used to show the importance of Novartis as a driver of research and development (case study on Novartis Pharma GmbH), a fast-growing global market leader in cutting-edge technology segments (case study on WaveLight), an impetus provider in a structurally weak region (case study on Salutas Pharma) and an investor in the manufacturing sector (case study on MARS Campus).
In 2016, the effects on gross value-added, employment and public revenues were recalculated. The new results can be found here.PDF Download of this publication